CN109053855A - A kind of synthetic method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane - Google Patents

A kind of synthetic method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane Download PDF

Info

Publication number
CN109053855A
CN109053855A CN201811166826.XA CN201811166826A CN109053855A CN 109053855 A CN109053855 A CN 109053855A CN 201811166826 A CN201811166826 A CN 201811166826A CN 109053855 A CN109053855 A CN 109053855A
Authority
CN
China
Prior art keywords
preparation
androstane
beta
epoxy
epoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811166826.XA
Other languages
Chinese (zh)
Other versions
CN109053855B (en
Inventor
顾光志
金炜华
潘建洪
陈凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIZHOU XIANJU PHARMACEUTICAL Co Ltd
Original Assignee
TAIZHOU XIANJU PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAIZHOU XIANJU PHARMACEUTICAL Co Ltd filed Critical TAIZHOU XIANJU PHARMACEUTICAL Co Ltd
Priority to CN201811166826.XA priority Critical patent/CN109053855B/en
Publication of CN109053855A publication Critical patent/CN109053855A/en
Application granted granted Critical
Publication of CN109053855B publication Critical patent/CN109053855B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention relates to pharmaceutical chemistry technical fields, disclose a kind of preparation method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane of rocuronium important intermediate, the preparation method the following steps are included: (1) in ball grinder,-2 α of 17- Acetoxyandrost is added together, 16 α-di-epoxide, pyrrolidines and silica gel are reacted under certain mechanical lapping frequency;(2) reaction mixture is post-treated and by being recrystallized to give-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane.Preparation method of the present invention has many advantages, such as that reaction yield is high, the time is short, selectivity is good, easy to operate, pollution is few, is a kind of green chemical synthesis method with preferable popularization and application foreground.

Description

A kind of synthetic method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane
Technical field
The present invention relates to pharmaceutical chemistry technical fields, and in particular to -2 alpha-epoxy-17 of a kind of 16 beta-tetrahydro pyrrole radicals androstane - The preparation method of ketone.
Background technique
- 2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane is to synthesize the important intermediate of rocuronium.Rocuronium is A kind of novel non depolarization sterol muscle relaxant, have it is rapid-action, in vivo without accumulation, without histamine release, to cardiovascular system press down Production has become the novel narcotics for substituting Scoline with weak and without advantages such as anaphylactoid reactions.Clinically, Luo Ku Bromine ammonium is widely used in operations on cranium and brain, Ophthalmic Emergency operation and the anesthesia of potential renal insufficiency patient etc..
Before the present invention, existing technology be with -2 α of 17- Acetoxyandrost, 16 α-di-epoxide as raw material, 16-2 α of beta-tetrahydro pyrrole radicals androstane-epoxy-is prepared by hydrolyzed under basic conditions and pyrrolidines open loop two-step reaction 17- ketone (WO2007033348A2).The disadvantages of this method is as follows: needing using a large amount of organic solvents, and reacts and need to return in high temperature It is carried out under the conditions of stream;Reaction selectivity is poor, and impurity separating difficulty is high;The method that the separation of product uses elutriation generates a large amount of Waste liquid is not easily recycled processing.
An important directions of the mechanico-chemical reaction technology that organic solvent-free participates in as the development of Green Chemistry, have become For one of the research hotspot of organic synthesis field in recent years.Mechanical attrition method can not only substantially reduce the solvent in reaction process It uses, can also solve that prior synthesizing method such as reaction time length, poor selectivity, yield is low, post-processing is numb to a certain extent The problems such as tired.Therefore, a kind of efficient, environmental protection and easily industrialization -2 alpha-epoxy-17 of 16 beta-tetrahydro pyrrole radicals androstane-is developed Ketone synthetic method, economic and social benefit with higher.
Summary of the invention
The purpose of the present invention is to solve existing-2 alpha-epoxy-17 -one synthetic method institutes of 16 beta-tetrahydro pyrrole radicals androstane The defects of existing poor selectivity, impurity are not readily separated and waste liquid amount is big provides a kind of high income, low in the pollution of the environment, easy to be high The new method of-2 alpha-epoxy-17 -one of the 16 beta-tetrahydro pyrrole radicals androstane synthesis of effect.
In order to achieve the above object of the invention, the present invention specifically uses following technical scheme:
A kind of preparation method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane shown in Formula II, it is characterised in that institute The preparation method stated the following steps are included:
(1) in ball grinder, -2 α of 17- Acetoxyandrost shown in Formulas I, 16 α-di-epoxide, pyrroles are added together Alkane, stainless steel ball and silica gel, setting ball mill running frequency carry out mechanical lapping reaction within the scope of 5-20Hz;
(2) reaction mixture is post-treated and is recrystallized to give 16-2 α of beta-tetrahydro pyrrole radicals androstane-ring shown in Formula II Oxygen -17- ketone;
- 2 α of 17- Acetoxyandrost shown in the formula (I), the molar ratio of 16 α-di-epoxide and pyrrolidines For 1:0.8-20;
The mass ratio that feeds intake of -2 α of 17- Acetoxyandrost shown in the Formulas I, 16 α-di-epoxide and silica gel is 1:2-20。
Preferably, -2 α of 17- Acetoxyandrost shown in the Formulas I, 16 α-di-epoxide feed intake with pyrrolidines Molar ratio is 1:1-8.
Preferably, -2 α of 17- Acetoxyandrost shown in the Formulas I, 16
The mass ratio that feeds intake of α-di-epoxide and silica gel is 1:2-10.
Preferably, the ball mill running frequency setting range is 8-16Hz.
Preferably, the total time of the mechanical ball mill reaction is 10-60 minutes.
Preferably, the recrystallization solvent uses methanol, ethyl alcohol, isopropanol, ethyl acetate, acetone, n-hexane, stone The mixed solvent of one or more of oily ether, water.
The reaction mixture post-processing approach are as follows: after reaction, reaction mixture is transferred to from ball grinder Beaker adds a small amount of organic solvent to impregnate, is directly thickened to do by filtrate after filtering.
Preferably, immersion solvent in the last handling process be ethyl acetate, methylene chloride, acetone, n-hexane, The mixed solvent of one or more of toluene, tetrahydrofuran, petroleum ether.
Preferably, -2 α of 17- Acetoxyandrost shown in the immersion solvent and formula (I), 16 α-di-epoxide Volume mass ratio is 5-10:1.
The present invention compared with prior art, has the beneficial effect that:
1) reaction step is reduced to a step, good reaction selectivity, high income by two steps.
2) mechanical lapping reaction process is without using organic solvent, to drastically reduce organic solvent in preparation process Use.
3) easy to operate, post-processing is simple, compares more existing elutriation product isolation technics, is divided by way of recrystallization Quantity of three wastes can be greatly reduced from purified product.
Specific embodiment
The present invention is described further combined with specific embodiments below, but protection scope of the present invention is not limited in This:
Embodiment 1
- 2 α of 3.46g (10mmol) 17- Acetoxyandrost, 16 α-di-epoxide, 6g are added in ball grinder (50mmol) pyrrolidines and 17.3g silica gel set ball mill running frequency as 15Hz, and mechanical lapping stops after twenty minutes.It will be complete Portion's reaction mixture is transferred in 50mL beaker from grinding pot, and 20mL methylene chloride is added and impregnates 1 hour.Filtering, filtrate is dense It is reduced to after doing, the mixed solvent (10:1) that methanol and water is added recrystallizes, and obtains 16 beta-tetrahydro pyrrole radicals androstane -2 of white solid Alpha-epoxy-17 -one 3.21g, yield 90%.
Through detecting, the concrete property of product is as follows:
Fusing point: 167.2-168.9 DEG C,1H NMR(400MHz,CDCl3)δ3.18-3.12(m,2H),2.94-2.90(m, 1H),2.78-2.72(m,2H),2.62-2.60(m,2H),2.17-2.08(m,1H),1.96-1.91(m,2H),1.85-1.71 (m,5H),1.67-0.95(m,13H),0.91(s,3H),0.80(s,3H),0.75-0.68(m,1H).13C NMR(100MHz, CDCl3)218.7,69.1,54.0,52.3,51.8,50.9,47.6,47.0,38.2,36.3,34.5,33.9,32.0,30.7, 29.0,28.1,26.6,23.2,20.1,14.0,12.9.
Embodiment 2
It is only that in step (1) with step, difference by -2 α of 17- Acetoxyandrost, 16 α-according to the method for embodiment 1 The molar ratio of di-epoxide and pyrrolidines is adjusted to 1:3, yield 78%.
Embodiment 3
It is only that in step (1) with step, difference by -2 α of 17- Acetoxyandrost, 16 α-according to the method for embodiment 1 The molar ratio of di-epoxide and pyrrolidines is adjusted to 1:8, yield 94%.
Embodiment 4
It is only that in step (1) with step, difference by -2 α of 17- Acetoxyandrost, 16 α-according to the method for embodiment 1 The mass ratio of di-epoxide and silica gel is adjusted to 1:3, yield 80%.
Embodiment 5
It is only that in step (1) with step, difference by -2 α of 17- Acetoxyandrost, 16 α-according to the method for embodiment 1 The mass ratio of di-epoxide and silica gel is adjusted to 1:10, yield 88%.
Embodiment 6
According to the method for embodiment 1 and step, difference, which is only that in step (1), is adjusted to 10 for the mechanical ball mill reaction time Minute, yield 81%.
Embodiment 7
According to the method for embodiment 1 and step, difference, which is only that in step (1), is adjusted to 50 for the mechanical ball mill reaction time Minute, yield 91%.
Embodiment 8
According to the method for embodiment 1 and step, difference, which is only that in step (1), is changed to ethyl alcohol, yield for recrystallization solvent It is 65%.
Embodiment 9
According to the method for embodiment 1 and step, difference, which is only that in step (1), is changed to n-hexane for recrystallization solvent: second Acetoacetic ester (10:1), yield 78%.
Embodiment 10
According to the method for embodiment 1 and step, difference, which is only that in step (1), is changed to acetone for recrystallization solvent: water (10:1), yield 76%.
Embodiment 11
According to the method for embodiment 1 and step, difference, which is only that, changes the immersion solvent in step (1) in last handling process For ethyl acetate, yield 92%.
Embodiment 12
According to the method for embodiment 1 and step, difference, which is only that, changes the immersion solvent in step (1) in last handling process For acetone, yield 89%.

Claims (9)

1. the preparation method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane shown in a kind of Formula II, it is characterised in that described Preparation method the following steps are included:
(1) in ball grinder, together be added Formulas I shown in -2 α of 17- Acetoxyandrost, 16 α-di-epoxide, pyrrolidines, Stainless steel ball and silica gel, setting ball mill running frequency carry out mechanical lapping reaction within the scope of 5-20Hz;
(2) reaction mixture is post-treated and is recrystallized to give -2 alpha-epoxy-17 of 16 beta-tetrahydro pyrrole radicals androstane-shown in Formula II Ketone;
2. preparation method according to claim 1, it is characterised in that 17- Acetoxyandrost -2 shown in the formula (I) α, 16 α-di-epoxide and pyrrolidines molar ratio are 1:0.8-20, preferably 1:1-8.
3. preparation method according to claim 1, it is characterised in that 17- Acetoxyandrost -2 shown in the formula (I) The mass ratio that feeds intake of α, 16 α-di-epoxide and silica gel is 1:2-20, preferably 1:2-10.
4. preparation method according to claim 1, it is characterised in that set ball mill running frequency is 5-20Hz, excellent Select 8-16Hz.
5. preparation method according to claim 1, it is characterised in that the total time of the ball-milling reaction is 10-60 minutes.
6. preparation method according to claim 1, it is characterised in that the recrystallization solvent is using methanol, ethyl alcohol, different The mixed solvent of one or more of propyl alcohol, ethyl acetate, acetone, n-hexane, petroleum ether, water.
7. preparation method according to claim 1, it is characterised in that the reaction mixture post-processing approach are as follows: reaction After, reaction mixture is transferred to beaker from ball grinder, a small amount of organic solvent is added to impregnate, it is after filtering that filtrate is directly dense It is reduced to dry.
8. preparation method according to claim 7, it is characterised in that the organic solvent is ethyl acetate, dichloromethane The mixed solvent of one or more of alkane, acetone, n-hexane, toluene, tetrahydrofuran, petroleum ether.
9. preparation method according to claim 7, it is characterised in that 17- acetyl oxygen shown in the organic solvent and Formulas I - 2 α of base androstane, the volume mass ratio of 16 α-di-epoxide are 5-10:1.
CN201811166826.XA 2018-10-08 2018-10-08 Synthesis method of 16 β -tetrahydropyrrole androstane-2 α -epoxy-17-ketone Active CN109053855B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811166826.XA CN109053855B (en) 2018-10-08 2018-10-08 Synthesis method of 16 β -tetrahydropyrrole androstane-2 α -epoxy-17-ketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811166826.XA CN109053855B (en) 2018-10-08 2018-10-08 Synthesis method of 16 β -tetrahydropyrrole androstane-2 α -epoxy-17-ketone

Publications (2)

Publication Number Publication Date
CN109053855A true CN109053855A (en) 2018-12-21
CN109053855B CN109053855B (en) 2020-02-14

Family

ID=64767342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811166826.XA Active CN109053855B (en) 2018-10-08 2018-10-08 Synthesis method of 16 β -tetrahydropyrrole androstane-2 α -epoxy-17-ketone

Country Status (1)

Country Link
CN (1) CN109053855B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114437169A (en) * 2022-01-25 2022-05-06 台州仙琚药业有限公司 Synthesis method of drospirenone key intermediate bromide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090852A (en) * 1992-11-02 1994-08-17 佐尔坦·图巴 Androstane derivative and pharmaceutical composition thereof and preparation method
WO2007033348A2 (en) * 2005-09-13 2007-03-22 Sicor, Inc. Process for the synthesis of rocuronium bromide
CN101323636A (en) * 2007-06-15 2008-12-17 复旦大学 Preparation of rocuronium
CN101381390A (en) * 2007-09-05 2009-03-11 王加旺 Synthetic method of bromamines muscle relaxant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090852A (en) * 1992-11-02 1994-08-17 佐尔坦·图巴 Androstane derivative and pharmaceutical composition thereof and preparation method
WO2007033348A2 (en) * 2005-09-13 2007-03-22 Sicor, Inc. Process for the synthesis of rocuronium bromide
CN101323636A (en) * 2007-06-15 2008-12-17 复旦大学 Preparation of rocuronium
CN101381390A (en) * 2007-09-05 2009-03-11 王加旺 Synthetic method of bromamines muscle relaxant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
严昕等: "罗库溴铵重要中间体17β-羟基-16β-四氢吡咯基雄甾-2(3)α-环氧化合物的合成工艺改进", 《复旦大学(医学版)》 *
夏树人等: "机械力化学工艺在医药材料合成中的研究进展", 《材料导报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114437169A (en) * 2022-01-25 2022-05-06 台州仙琚药业有限公司 Synthesis method of drospirenone key intermediate bromide

Also Published As

Publication number Publication date
CN109053855B (en) 2020-02-14

Similar Documents

Publication Publication Date Title
EA015967B1 (en) Process for the preparation of a benzimidazole derivative
CN107383026B (en) A kind of synthetic method of 7- methylol -2,5- diaza spiro [3,4] octane -2- t-butyl formate
JP2022163113A (en) Process for preparing purine derivatives
CN105131071B (en) A kind of synthetic method of the Tosylhydrazone of 25 hydroxy cholesterol acetate 7
CN102336696A (en) Intermediate for synthesizing 4-AA and preparation method and application thereof
CN109053855A (en) A kind of synthetic method of-2 alpha-epoxy-17 -one of 16 beta-tetrahydro pyrrole radicals androstane
EP3201171B1 (en) Method of preparing intermediate of salmeterol
Orita et al. Integration of Solventless Reaction in a Multi‐Step Process: Application to an Efficient Synthesis of PA‐824
CN104703967B (en) The process for purification of fluvoxamine free alkali and the preparation method of the high-purity fluvoxamine maleate using which
CN108484451A (en) A kind of method that one kettle way prepares 1,2- alkamine compounds
CN105461529A (en) Preparing method for 1,1,3-trichloroacetone
CN109761845B (en) Synthesis method of N-nitroso-4-aminobutyric acid ester compound
CN114989061A (en) Preparation method of brivaracetam
CN111087352B (en) Preparation method of 3-trifluoroalkyl quinoxalinone compound
CN113045583B (en) Preparation method of pinoxaden metabolite
CN110317170B (en) Green synthesis method of 3-phenanthridinyl propyl formate compound
CN105439978A (en) Preparation method of acotiamide intermediate
CN112321642A (en) Ruidexiwei related substance and preparation method and application thereof
CN106831811B (en) A method of preparing high-content nimoctin
CN114044762B (en) Preparation method of chlormezanone intermediate
CN116143676B (en) Preparation method of pyrrolidin-2-yl (hydroxy) methyl compound
RU2791469C2 (en) Method for the preparation of 2-(5-methoxy isochroman-1-yl)-4,5-dihydro-1h-imidazole and its hydrosulfate
CN110551129B (en) Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester
US10633314B2 (en) Method for the conversion of Abienol to Sclarediol
CN111253321A (en) Preparation method of 2-methoxy-5-amino-4-methylpyrimidine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant